Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) · filed Jun 2, 2022

Accession no.
0001209191-22-033343
Filed
Jun 2, 2022, 8:08 AM ET
Trade date
Jun 1, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 8 non-derivative transactions. Open-market purchases total $147.6K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2022Common StockPPurchaseAcquired+5,000$2.93+$14,650196,061,694Indirect
Jun 1, 2022Common StockPPurchaseAcquired+20,000$2.94+$58,700196,081,694Indirect
Jun 1, 2022Common StockPPurchaseAcquired+5,000$2.95+$14,750196,086,694Indirect
Jun 1, 2022Common StockPPurchaseAcquired+500$2.96+$1,480196,087,194Indirect
Jun 1, 2022Common StockPPurchaseAcquired+14,900$2.97+$44,178.5196,102,094Indirect
Jun 1, 2022Common StockPPurchaseAcquired+500$2.99+$1,492.5196,102,594Indirect
Jun 1, 2022Common StockPPurchaseAcquired+3,800$3.02+$11,457196,106,394Indirect
Jun 1, 2022Common StockPPurchaseAcquired+300$3.02+$906196,106,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)